Cochrane Abstracts
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis New
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis New is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Biologics or Tofacitinib for Rheumatoid Arthritis in Incomplete Responders to Methotrexate or Other Traditional Disease‐modifying Anti‐rheumatic Drugs: a Systematic Review and Network Meta‐analysis New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437293/all/Biologics_or_tofacitinib_for_rheumatoid_arthritis_in_incomplete_responders_to_methotrexate_or_other_traditional_disease‐modifying_anti‐rheumatic_drugs:_a_systematic_review_and_network_meta‐analysis_New. Accessed 07 February 2023.
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437293/all/Biologics_or_tofacitinib_for_rheumatoid_arthritis_in_incomplete_responders_to_methotrexate_or_other_traditional_disease‐modifying_anti‐rheumatic_drugs:_a_systematic_review_and_network_meta‐analysis_New. Accessed February 7, 2023.
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437293/all/Biologics_or_tofacitinib_for_rheumatoid_arthritis_in_incomplete_responders_to_methotrexate_or_other_traditional_disease‐modifying_anti‐rheumatic_drugs:_a_systematic_review_and_network_meta‐analysis_New
Biologics or Tofacitinib for Rheumatoid Arthritis in Incomplete Responders to Methotrexate or Other Traditional Disease‐modifying Anti‐rheumatic Drugs: a Systematic Review and Network Meta‐analysis New [Internet]. In: Cochrane Abstracts. [cited 2023 February 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437293/all/Biologics_or_tofacitinib_for_rheumatoid_arthritis_in_incomplete_responders_to_methotrexate_or_other_traditional_disease‐modifying_anti‐rheumatic_drugs:_a_systematic_review_and_network_meta‐analysis_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis New
ID - 437293
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437293/all/Biologics_or_tofacitinib_for_rheumatoid_arthritis_in_incomplete_responders_to_methotrexate_or_other_traditional_disease‐modifying_anti‐rheumatic_drugs:_a_systematic_review_and_network_meta‐analysis_New
DB - Evidence Central
DP - Unbound Medicine
ER -
